| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000229999.2 |
Docetaxel |
Breast invasive carcinoma |
0.040415524 |
Resistant |
| ENSG00000229999.2 |
Docetaxel |
Brain lower grade glioma |
0.005739069 |
Resistant |
| ENSG00000229999.2 |
Docetaxel |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.005590499 |
Sensitive |
| ENSG00000229999.2 |
Docetaxel |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026760655 |
Sensitive |
